Potential of Anti-CMV Immunoglobulin Cytotect CP<sup>®</sup> In Vitro and Ex Vivo in a First-Trimester Placenta Model

Potential of Anti-CMV Immunoglobulin Cytotect CP<sup>®</sup> In Vitro and Ex Vivo in a First-Trimester Placenta Model

Background: Congenital CMV infection is the leading cause of neonatal neurological deficit. We herein studied in vitro and ex vivo the potential of the hyperimmune globulin Cytotect CP<sup>®</sup> (Biotest, Germany) for congenital infection prevention and treatment. Methods: In vitro neu...

Full description

Bibliographic Details
Main Authors: Perrine Coste Mazeau, Chloé Jacquet, Clotilde Muller, Mathis Courant, Chahrazed El Hamel, Thierry Chianea, Sébastien Hantz, Sophie Alain
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Microorganisms
Subjects:
congenital cytomegalovirus
hyperimmune immunoglobulins
Cytotect CP<sup>®</sup>
Online Access:https://www.mdpi.com/2076-2607/10/4/694

Internet

https://www.mdpi.com/2076-2607/10/4/694

Similar Items